Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Microbot Medical Inc. Director's Dealing 2011

Mar 15, 2011

33819_dirs_2011-03-15_779a3eab-c51f-4d73-983a-366d3c832bc1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STEMCELLS INC (STEM)
CIK: 0000883975
Period of Report: 2011-03-11

Reporting Person: MCGLYNN MARTIN M (Director, President & CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-03-11 Common Stock F 50435 $0.81 Disposed 1500213 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 41132 Indirect

Footnotes

F1: Includes (1) 1,200,000 restricted stock units, with 400,000 of this grant vesting on each of June 25, 2011, June 25, 2012 and June 25, 2013 and (2) 176,000 restricted stock units, with 58,667 of this grant vesting on each of May 15, 2011, May 15, 2012 and May 15, 2013.

F2: Shares held in 401(k) account in accordance with issuer's employer-match policies.